Edgar Lomax Company’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.2M Sell
227,655
-3,735
-2% -$414K 1.6% 27
2025
Q1
$25.9M Buy
231,390
+105,800
+84% +$11.9M 1.62% 24
2024
Q4
$11.6M Sell
125,590
-2,400
-2% -$222K 0.75% 43
2024
Q3
$10.7M Sell
127,990
-1,990
-2% -$167K 0.66% 50
2024
Q2
$8.92M Sell
129,980
-2,330
-2% -$160K 0.58% 51
2024
Q1
$9.69M Buy
132,310
+32,411
+32% +$2.37M 0.6% 52
2023
Q4
$8.09M Sell
99,899
-4,025
-4% -$326K 0.53% 43
2023
Q3
$7.79M Sell
103,924
-1,745
-2% -$131K 0.53% 43
2023
Q2
$8.14M Sell
105,669
-1,416
-1% -$109K 0.54% 43
2023
Q1
$8.88M Sell
107,085
-115,415
-52% -$9.58M 0.57% 42
2022
Q4
$19.1M Sell
222,500
-1,290
-0.6% -$111K 1.16% 34
2022
Q3
$13.8M Sell
223,790
-2,545
-1% -$157K 0.95% 39
2022
Q2
$14M Buy
226,335
+6,180
+3% +$382K 0.88% 38
2022
Q1
$13.1M Buy
220,155
+60,335
+38% +$3.59M 0.77% 39
2021
Q4
$11.6M Sell
159,820
-1,515
-0.9% -$110K 0.69% 44
2021
Q3
$11.3M Sell
161,335
-2,950
-2% -$206K 0.72% 45
2021
Q2
$11.3M Sell
164,285
-6,350
-4% -$437K 0.7% 45
2021
Q1
$11M Sell
170,635
-4,480
-3% -$290K 0.69% 46
2020
Q4
$10.2M Sell
175,115
-3,050
-2% -$178K 0.69% 42
2020
Q3
$11.3M Buy
178,165
+7,200
+4% +$455K 0.87% 37
2020
Q2
$13.2M Buy
170,965
+3,315
+2% +$255K 1.05% 30
2020
Q1
$12.5M Buy
167,650
+23,800
+17% +$1.78M 1.11% 29
2019
Q4
$9.35M Sell
143,850
-3,400
-2% -$221K 0.6% 47
2019
Q3
$9.33M Sell
147,250
-1,500
-1% -$95.1K 0.62% 47
2019
Q2
$10.1M Sell
148,750
-2,250
-1% -$152K 0.68% 45
2019
Q1
$9.82M Buy
151,000
+21,300
+16% +$1.38M 0.67% 47
2018
Q4
$8.11M Sell
129,700
-1,900
-1% -$119K 0.62% 45
2018
Q3
$10.2M Sell
131,600
-4,500
-3% -$347K 0.68% 45
2018
Q2
$9.64M Buy
136,100
+950
+0.7% +$67.3K 0.68% 46
2018
Q1
$10.2M Buy
+135,150
New +$10.2M 0.73% 42
2017
Q1
Sell
-222,142
Closed -$15.9M 65
2016
Q4
$15.9M Sell
222,142
-20,183
-8% -$1.45M 1.02% 37
2016
Q3
$19.2M Sell
242,325
-150
-0.1% -$11.9K 1.19% 32
2016
Q2
$20.2M Buy
242,475
+12,325
+5% +$1.03M 1.27% 29
2016
Q1
$21.1M Buy
230,150
+122,250
+113% +$11.2M 1.45% 24
2015
Q4
$10.9M Buy
+107,900
New +$10.9M 0.8% 40